United States Pharmaceuticals

Aptinyx Inc (APTX)

Track

Stock chart
Ticker: APTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Miller Joan W.
1 purchase — total 50,091 USD
Buy 13 Jan 2022
Value US$4,716,130.58 | Price 453.20 | Shares 9,306
Buy 6 Dec 2021
Value US$2,202,447.13 | Price 455.19 | Shares 43,580
Buy 2 Dec 2021
Value US$101,700.00 | Price 2.26 | Shares 45,000
Buy 12 Nov 2021
Value US$179,040.00 | Price 2.40 | Shares 74,600
Buy 11 Nov 2021
Value US$12,960.00 | Price 2.40 | Shares 5,400
Buy 26 Oct 2020
Value US$9,999,999.00 | Price 3.00 | Shares 3,333,333
Buy 22 Jan 2020
Value US$10,413.46 | Price 4.79 | Shares 2,174
Buy 14 Jan 2020
Value US$9,999,999.00 | Price 3.00 | Shares 3,333,333
Buy 10 Jan 2020
Value US$500,001.00 | Price 3.00 | Shares 166,667
Buy 10 Jan 2020
Value US$285,000.00 | Price 3.00 | Shares 95,000
Buy 10 Jan 2020
Value US$1,049,418.00 | Price 3.00 | Shares 349,806
Buy 10 Jan 2020
Value US$314,826.00 | Price 3.00 | Shares 104,942
Buy 10 Jan 2020
Value US$361,359.00 | Price 3.00 | Shares 120,453
Buy 10 Jan 2020
Value US$470,760.00 | Price 3.00 | Shares 156,920
Buy 10 Jan 2020
Value US$346,101.00 | Price 3.00 | Shares 115,367
Buy 10 Jan 2020
Value US$457,536.00 | Price 3.00 | Shares 152,512
Buy 10 Jan 2020
Value US$150,000.00 | Price 3.00 | Shares 50,000
Buy 10 Jan 2020
Value US$75,000.00 | Price 3.00 | Shares 25,000
Buy 10 Jan 2020
Value US$105,000.00 | Price 3.00 | Shares 35,000
Buy 22 Nov 2019
Value US$161,750.00 | Price 3.24 | Shares 50,000
Buy 8 May 2019
Value US$372,798.80 | Price 3.86 | Shares 96,580
Buy 7 May 2019
Value US$12,825.00 | Price 3.75 | Shares 3,420
Buy 28 Jan 2019
Value US$5,533.50 | Price 5.27 | Shares 1,050
Buy 25 Jan 2019
Value US$64,568.70 | Price 5.54 | Shares 11,655
Buy 24 Jan 2019
Value US$73,664.40 | Price 5.52 | Shares 13,345
Buy 18 Jan 2019
Value US$54,500.00 | Price 5.45 | Shares 10,000
Buy 25 Jun 2018
Value US$2,400,000.00 | Price 16.00 | Shares 150,000
Buy 25 Jun 2018
Value US$2,000,000.00 | Price 16.00 | Shares 125,000
Buy 25 Jun 2018
Value US$2,000,000.00 | Price 16.00 | Shares 125,000
Buy 25 Jun 2018
Value US$48,000.00 | Price 16.00 | Shares 3,000
Buy 25 Jun 2018
Value US$6,400,000.00 | Price 16.00 | Shares 400,000
Buy 25 Jun 2018
Value US$839,536.00 | Price 16.00 | Shares 52,471
Buy 25 Jun 2018
Value US$251,856.00 | Price 16.00 | Shares 15,741
Buy 25 Jun 2018
Value US$289,088.00 | Price 16.00 | Shares 18,068
Buy 25 Jun 2018
Value US$376,608.00 | Price 16.00 | Shares 23,538
Buy 25 Jun 2018
Value US$276,880.00 | Price 16.00 | Shares 17,305
Buy 25 Jun 2018
Value US$366,032.00 | Price 16.00 | Shares 22,877
Buy 25 Jun 2018
Value US$2,400,000.00 | Price 16.00 | Shares 150,000
Buy 25 Jun 2018
Value US$385,600.00 | Price 16.00 | Shares 24,100
Buy 25 Jun 2018
Value US$107,200.00 | Price 16.00 | Shares 6,700
Buy 25 Jun 2018
Value US$2,400,000.00 | Price 16.00 | Shares 150,000
Buy 25 Jun 2018
Value US$16,000.00 | Price 16.00 | Shares 1,000
Buy 25 Jun 2018
Value US$2,000,000.00 | Price 16.00 | Shares 125,000
Buy 25 Jun 2018
Value US$2,000,000.00 | Price 16.00 | Shares 125,000
Buy 25 Jun 2018
Value US$28,800.00 | Price 16.00 | Shares 1,800
Buy 25 Jun 2018
Value US$96,000.00 | Price 16.00 | Shares 6,000
Buy 25 Jun 2018
Value US$38,400.00 | Price 16.00 | Shares 2,400
Buy 25 Jun 2018
Value US$2,400,000.00 | Price 16.00 | Shares 150,000
Buy 25 Jun 2018
Value US$97,600.00 | Price 16.00 | Shares 6,100
Buy 25 Jun 2018
Value US$272,000.00 | Price 16.00 | Shares 17,000
Buy 25 Jun 2018
Value US$839,536.00 | Price 16.00 | Shares 52,471
Buy 25 Jun 2018
Value US$251,856.00 | Price 16.00 | Shares 15,741
Buy 25 Jun 2018
Value US$289,088.00 | Price 16.00 | Shares 18,068
Buy 25 Jun 2018
Value US$376,608.00 | Price 16.00 | Shares 23,538
Buy 25 Jun 2018
Value US$276,880.00 | Price 16.00 | Shares 17,305
Buy 25 Jun 2018
Value US$366,032.00 | Price 16.00 | Shares 22,877
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-18 2022-01-13 B Purchase
Miller Joan W.
Non-Executive Director
9,306 -42.6%
453.20
US$4,716,131 		9,306 -42.6% 453.20 US$4,716,131
2021-12-08 2021-12-06 B Purchase
3.5
RIEDEL NORBERT G

CEO

Executive Director
43,580 +5.7%
455.19
US$2,202,447 		43,580 +5.7% 455.19 US$2,202,447
2021-12-06 2021-12-02 B Purchase
KHANNA ASHISH

CFO AND CBO

Officer
53,537 +34.1%
319.42
US$2,805,324 		53,537 +34.1% 319.42 US$2,805,324
2021-11-15 2021-11-12 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
74,600 +51.6%
2.40
US$179,040 		74,600 +51.6% 2.40 US$179,040
2021-11-15 2021-11-11 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
5,400 +3.9%
2.40
US$12,960 		5,400 +3.9% 2.40 US$12,960
2020-10-27 2020-10-26 B Purchase
2.7
Bain Capital Life Sciences Investors, LLC
Large shareholder
3,333,333 +60.0%
3.00
US$9,999,999 		3,333,333 +60.0% 3.00 US$9,999,999
2020-01-23 2020-01-22 B Purchase
Sherman Rachel E.
2,174 +inf%
4.79
US$10,413 		2,174 +inf% 4.79 US$10,413
2020-01-16 2020-01-14 B Purchase
4.0
Koppel Adam
Large shareholder
3,333,333 +149.8%
3.00
US$9,999,999 		3,333,333 +149.8% 3.00 US$9,999,999
2020-01-14 2020-01-10 B Purchase
3.6
ENRIGHT PATRICK G
166,667 +5.2%
3.00
US$500,001 		166,667 +5.2% 3.00 US$500,001
2020-01-14 2020-01-10 B Purchase
3.6
ENRIGHT PATRICK G
95,000 +inf%
3.00
US$285,000 		95,000 +inf% 3.00 US$285,000
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
349,806 +31.3%
3.00
US$1,049,418 		349,806 +31.3% 3.00 US$1,049,418
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
104,942 +31.3%
3.00
US$314,826 		104,942 +31.3% 3.00 US$314,826
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
120,453 +31.3%
3.00
US$361,359 		120,453 +31.3% 3.00 US$361,359
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
156,920 +28.3%
3.00
US$470,760 		156,920 +28.3% 3.00 US$470,760
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
115,367 +28.3%
3.00
US$346,101 		115,367 +28.3% 3.00 US$346,101
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
152,512 +28.3%
3.00
US$457,536 		152,512 +28.3% 3.00 US$457,536
2020-01-14 2020-01-10 B Purchase
HOMBACH ROBERT J.
50,000 +56.1%
3.00
US$150,000 		50,000 +56.1% 3.00 US$150,000
2020-01-14 2020-01-10 B Purchase
3.2
Gosebruch Henry O
25,000 +25.0%
3.00
US$75,000 		25,000 +25.0% 3.00 US$75,000
2020-01-14 2020-01-10 B Purchase
3.5
RIEDEL NORBERT G

CEO and President

Executive Director
35,000 +inf%
3.00
US$105,000 		35,000 +inf% 3.00 US$105,000
2019-11-26 2019-11-22 B Purchase HOMBACH ROBERT J. Non-Executive Director
50,000 +127.9%
3.24
US$161,750 		50,000 +127.9% 3.24 US$161,750
2019-05-09 2019-05-08 B Purchase
3.2
Gosebruch Henry O
96,580 +2824.0%
3.86
US$372,799 		96,580 +2824.0% 3.86 US$372,799
2019-05-09 2019-05-07 B Purchase
3.2
Gosebruch Henry O
3,420 +inf%
3.75
US$12,825 		3,420 +inf% 3.75 US$12,825
2019-01-30 2019-01-28 B Purchase
Madsen Torsten M.

Chief Medical Officer

Officer
1,050 +0.5%
5.27
US$5,534 		1,050 +0.5% 5.27 US$5,534
2019-01-28 2019-01-25 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
11,655 +31.1%
5.54
US$64,569 		11,655 +31.1% 5.54 US$64,569
2019-01-28 2019-01-24 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
13,345 +55.4%
5.52
US$73,664 		13,345 +55.4% 5.52 US$73,664
2019-01-18 2019-01-18 B Purchase
KHANNA ASHISH

CFO and CBO

Officer
10,000 +3.7%
5.45
US$54,500 		10,000 +3.7% 5.45 US$54,500
2018-06-26 2018-06-25 B Purchase Frazier Life Sciences VIII, L.P. Large shareholder
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase New Leaf Venture Management III, L.L.C. Large shareholder
125,000 +51.4%
16.00
US$2,000,000 		125,000 +51.4% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase New Leaf Venture Management III, L.L.C. Large shareholder
125,000 +4.5%
16.00
US$2,000,000 		125,000 +4.5% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase MOSKAL JOSEPH R.

Chief Scientific Officer

Officer
3,000 +0.8%
16.00
US$48,000 		3,000 +0.8% 16.00 US$48,000
2018-06-26 2018-06-25 B Purchase Koppel Adam Non-Executive Director
400,000 +21.9%
16.00
US$6,400,000 		400,000 +21.9% 16.00 US$6,400,000
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
52,471 +4.9%
16.00
US$839,536 		52,471 +4.9% 16.00 US$839,536
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
15,741 +4.9%
16.00
US$251,856 		15,741 +4.9% 16.00 US$251,856
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
18,068 +4.9%
16.00
US$289,088 		18,068 +4.9% 16.00 US$289,088
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
23,538 +4.4%
16.00
US$376,608 		23,538 +4.4% 16.00 US$376,608
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
17,305 +4.4%
16.00
US$276,880 		17,305 +4.4% 16.00 US$276,880
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
22,877 +4.4%
16.00
US$366,032 		22,877 +4.4% 16.00 US$366,032
2018-06-26 2018-06-25 B Purchase Longitude Capital Partners II, LLC Large shareholder
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase HOMBACH ROBERT J. Non-Executive Director
24,100 +inf%
16.00
US$385,600 		24,100 +inf% 16.00 US$385,600
2018-06-26 2018-06-25 B Purchase KIDD ANDREW

Chief Commercial Officer

Officer
6,700 +275.4%
16.00
US$107,200 		6,700 +275.4% 16.00 US$107,200
2018-06-26 2018-06-25 B Purchase Topper James N Non-Executive Director Large shareholder
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase Madsen Torsten M.

Chief Medical Officer

Officer
1,000 +0.4%
16.00
US$16,000 		1,000 +0.4% 16.00 US$16,000
2018-06-26 2018-06-25 B Purchase Ratcliffe Liam Non-Executive Director Large shareholder
125,000 +51.4%
16.00
US$2,000,000 		125,000 +51.4% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase Ratcliffe Liam Non-Executive Director Large shareholder
125,000 +4.5%
16.00
US$2,000,000 		125,000 +4.5% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase KHANNA ASHISH

CFO and CBO

Officer
1,800 +inf%
16.00
US$28,800 		1,800 +inf% 16.00 US$28,800
2018-06-26 2018-06-25 B Purchase KHANNA ASHISH

CFO and CBO

Officer
6,000 +2.2%
16.00
US$96,000 		6,000 +2.2% 16.00 US$96,000
2018-06-26 2018-06-25 B Purchase RIEDEL NORBERT G

CEO and President

Executive Director
2,400 +88.3%
16.00
US$38,400 		2,400 +88.3% 16.00 US$38,400
2018-06-26 2018-06-25 B Purchase ENRIGHT PATRICK G
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase GANTZ WILBUR H
6,100 +8.2%
16.00
US$97,600 		6,100 +8.2% 16.00 US$97,600
2018-06-26 2018-06-25 B Purchase GANTZ WILBUR H
17,000 +4.8%
16.00
US$272,000 		17,000 +4.8% 16.00 US$272,000
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
52,471 +4.9%
16.00
US$839,536 		52,471 +4.9% 16.00 US$839,536
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
15,741 +4.9%
16.00
US$251,856 		15,741 +4.9% 16.00 US$251,856
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
18,068 +4.9%
16.00
US$289,088 		18,068 +4.9% 16.00 US$289,088
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
23,538 +4.4%
16.00
US$376,608 		23,538 +4.4% 16.00 US$376,608
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
17,305 +4.4%
16.00
US$276,880 		17,305 +4.4% 16.00 US$276,880
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
22,877 +4.4%
16.00
US$366,032 		22,877 +4.4% 16.00 US$366,032
Explore more

More insider trading research around Aptinyx Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America